Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.32%
1,100.57
-3.53
-0.32%
—1,104.101,103.921,108.751,097.16——
SIXC
Communications
SIXC
Communications
SIXC
+0.16%
605.15
+0.99
+0.16%
—604.16604.16610.19604.12——
SIXE
Energy
SIXE
Energy
SIXE
-0.22%
1,195.19
-2.62
-0.22%
—1,197.811,200.581,213.071,192.02——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.03%
1,739.91
-0.50
-0.03%
—1,740.411,739.551,750.271,730.60——
SIXM
Financials
SIXM
Financials
SIXM
+0.65%
638.56
+4.12
+0.65%
—634.44633.13639.87633.01——
SIXR
Staples
SIXR
Staples
SIXR
-1.11%
831.57
-9.33
-1.11%
—840.90839.53841.73831.10——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.82%
213.36
-1.77
-0.82%
—215.13215.13215.85213.24——
SIXT
Technology
SIXT
Technology
SIXT
+0.17%
3,234.18
+5.47
+0.17%
—3,228.713,225.623,235.433,198.95——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.02%
935.65
-0.22
-0.02%
—935.87938.37942.00935.65——
SIXV
Health care
SIXV
Health care
SIXV
-0.54%
1,449.26
-7.86
-0.54%
—1,457.121,452.741,466.881,449.18——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,382.45
-17.39
-0.72%
—2,399.842,389.712,394.612,371.22——
Q1 2026 earnings • released • EPS beat +35.12% • Revenue beat +5.07%
See results
INCY:NASDAQ
Incyte Corp
$95.72
+1.13%
(+1.06) 1D
$94.00
-1.79% (-1.71)
Pre-market
Closed: Apr 27, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INCY...
Open
$94.50
High
$97.66
Low
$94.50
Mkt. cap
19.05B
Avg. vol.
1.53M
Volume
52.82K
P/E ratio
14.93
52-wk high
$112.29
52-wk low
$57.29
EPS
$6.41
Beta
0.85
Shares outstanding
199.01M
No. of employees
3K
News stories
From sources across the web
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia. Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEOHervé Hoppenot
Employees2.84K
Founded2002
HeadquartersWilmington, Delaware, United States
SectorBiotechnology
Websiteincyte.com
Last report
Just released
Today, 8:00 AM
Fiscal Period
Q1 2026
Normalized EPS / Estimate
1.81/ (1.34 est.)USD
+35.12%beat
Revenue / Estimate
1.27B/ (1.21B est.)USD
+5.07%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
1.05B
1.22B
1.37B
1.51B
Cost of goods sold
473.77M
573.68M
605.58M
732.55M
Cost of revenue
473.77M
573.68M
605.58M
732.55M
Research and development expenses
36.70M
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
324.97M
330.26M
328.29M
388.96M
Operating expense
361.67M
330.26M
328.29M
388.96M
Total operating expenses
835.44M
903.94M
933.87M
1.12B
Operating income
217.46M
311.59M
432.11M
385.32M
Other non operating income
7.37M
6.54M
3.25M
4.22M
EBT including unusual items
234.19M
558.01M
482.31M
389.94M
EBT excluding unusual items
247.10M
342.67M
461.55M
419.71M
Income tax expense
75.99M
153.01M
58.14M
90.66M
Effective tax rate
32.45%
27.42%
12.05%
23.25%
Other operating expenses
-
-
-
-
Net income
158.20M
405.00M
424.17M
299.28M
Net profit margin
15.03%
33.32%
31.05%
19.86%
Earnings per share
1.16
1.57
2.26
1.80
Interest and investment income
22.93M
25.14M
26.78M
30.75M
Interest expense
-660.00K
-594.00K
-592.00K
-582.00K
Net interest expenses
22.27M
24.54M
26.19M
30.17M
Depreciation and amortization charges
-
-
-
-
EBITDA
239.82M
334.51M
456.13M
409.30M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer